2m 2m 2m 2m 2m 2m 2m
VIRIDIAN THERAPT (VRDN)
NASDAQ
$30.18+$0.12 (+0.38%)
Price as of Nov 18, 2026 3:41 PM EST- $3.4BMarket Cap
- 5.14%1-Year Change
- BiotechnologyIndustry
VIRIDIAN THERAPT (VRDN)
$30.18+$0.12 (+0.38%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 15.42% | 17.5M | +904,397 (+5.17%) | Sep 30, 2026 |
BLACKROCK, INC. | 8.22% | 9.3M | +777,662 (+8.34%) | Sep 30, 2026 |
PARADIGM BIOCAPITAL ADVISORS LP | 7.27% | 8.3M | +1.5M (+18.58%) | Sep 30, 2026 |
BELLEVUE GROUP AG | 6.26% | 7.1M | +377,409 (+5.31%) | Sep 30, 2026 |
KYNAM CAPITAL MANAGEMENT, LP | 5.41% | 6.1M | -305,877 (-4.98%) | Sep 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 5.07% | 5.8M | +954,571 (+16.58%) | Dec 31, 2024 |
VANGUARD GROUP INC | 4.94% | 5.6M | +1.3M (+22.81%) | Dec 31, 2025 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.93% | 4.5M | +402,249 (+9.00%) | Jun 30, 2026 |
FIDELITY SECURITIES FUND | 2.76% | 3.1M | +299,375 (+9.54%) | Jul 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.47% | 2.8M | 0 (0.00%) | Aug 31, 2026 |
FIDELITY ADVISOR SERIES VII | 2.24% | 2.5M | -100,000 (-3.93%) | Jul 31, 2026 |
Fidelity Rutland Square Trust II | 1.34% | 1.5M | -7,280 (-0.48%) | Aug 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 1.27% | 1.4M | +1.1M (+76.25%) | Jun 30, 2026 |
T. Rowe Price New Horizons Fund, Inc. | 1.19% | 1.4M | +303,738 (+22.47%) | Jun 30, 2026 |
Current Ownership Distribution
- Institutions1.5B (81.35%)
- Mutual Funds317.3M (17.69%)
- Insiders17.2M (0.96%)
- Other0 (0.00%)
Insider Transactions
- 0.96% (17.2M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 1Number of InsiderSelling (last 12 months)
- $418,989.52Amount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Tousignant Jennifer Chief Legal Officer | Exempt | Aug 19, 2026 | $0.00 | 10,000 | $0.00 | 114,072 |
Tousignant Jennifer Chief Legal Officer | Sell | Aug 19, 2026 | $103,194.00 | 4,212 | $24.50 | 0 |
Tousignant Jennifer Chief Legal Officer | Exempt | Aug 19, 2026 | $144,100.00 | 10,000 | $14.41 | 10,000 |
Tousignant Jennifer Chief Legal Officer | Sell | Aug 19, 2026 | $245,000.00 | 10,000 | $24.50 | 0 |
Tripuraneni Radhika Chief Medical Officer | Exempt | Aug 14, 2026 | $0.00 | 40,000 | $0.00 | 0 |
Tripuraneni Radhika Chief Medical Officer | Exempt | Aug 14, 2026 | $528,400.00 | 40,000 | $13.21 | 40,000 |
Gheuens Sarah | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
CAIN CHRISTOPHER W. | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
Moses Jennifer K. | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
Kiselak Tomas | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
Morris Arlene | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
Ajer Jeffrey Robert | Award | Jul 01, 2026 | $0.00 | 32,341 | $0.00 | 32,341 |
Harmon Seth Chief Financial Officer | Exempt | Mar 03, 2026 | $0.00 | 6,267 | $0.00 | 18,801 |
Mahoney Stephen F. President and CEO | Exempt | Mar 03, 2026 | $0.00 | 18,357 | $0.00 | 55,071 |
Beetham Thomas W. Chief Operating Officer | Exempt | Mar 03, 2026 | $0.00 | 9,409 | $0.00 | 28,227 |
Mahoney Stephen F. President and CEO | Exempt | Mar 03, 2026 | $0.00 | 18,357 | $0.00 | 40,757 |
Harmon Seth Chief Financial Officer | Exempt | Mar 03, 2026 | $0.00 | 6,267 | $0.00 | 9,881 |
Mahoney Stephen F. President and CEO | In Kind | Mar 03, 2026 | $223,623.64 | 7,627 | $29.32 | 33,130 |
Beetham Thomas W. Chief Operating Officer | Exempt | Mar 03, 2026 | $0.00 | 9,409 | $0.00 | 16,409 |
Harmon Seth Chief Financial Officer | In Kind | Mar 03, 2026 | $61,308.12 | 2,091 | $29.32 | 7,790 |
Beetham Thomas W. Chief Operating Officer | In Kind | Mar 03, 2026 | $92,006.16 | 3,138 | $29.32 | 13,271 |
Tousignant Jennifer Chief Legal Officer | Exempt | Mar 03, 2026 | $0.00 | 5,169 | $0.00 | 15,510 |
Tousignant Jennifer Chief Legal Officer | Exempt | Mar 03, 2026 | $0.00 | 5,169 | $0.00 | 5,169 |
Tousignant Jennifer Chief Legal Officer | In Kind | Mar 03, 2026 | $50,547.68 | 1,724 | $29.32 | 3,445 |
Mahoney Stephen F. President and CEO | Award | Mar 02, 2026 | $0.00 | 559,600 | $0.00 | 559,600 |
Tripuraneni Radhika Chief Medical Officer | Award | Mar 02, 2026 | $0.00 | 95,800 | $0.00 | 95,800 |
Mahoney Stephen F. President and CEO | Award | Mar 02, 2026 | $0.00 | 111,900 | $0.00 | 111,900 |
Harmon Seth Chief Financial Officer | Award | Mar 02, 2026 | $0.00 | 102,850 | $0.00 | 102,850 |
Tripuraneni Radhika Chief Medical Officer | Award | Mar 02, 2026 | $0.00 | 19,150 | $0.00 | 19,150 |
Beetham Thomas W. Chief Operating Officer | Award | Mar 02, 2026 | $0.00 | 176,550 | $0.00 | 176,550 |